MaxCyte Inc
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About MaxCyte Inc
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy MaxCyte Inc stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for MaxCyte Inc by name or ticker, choose the number of shares, and place your order.
The ticker symbol for MaxCyte Inc is MXCT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
MaxCyte Inc has its primary listing on NASDAQ. You can trade MaxCyte Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, MaxCyte Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include MaxCyte Inc as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like MaxCyte Inc.